GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: The Holocene, SAGE Publications, Vol. 19, No. 5 ( 2009-08), p. 747-756
    Abstract: Detailed diatom records within surface and core sediments from the Southern Bering Continental Shelf (SBCS) reveal that the Holocene evolution of sea-ice distribution is associated with low pressure patterns. Holocene sea-ice distribution over the SBCS was mainly controlled by the location of the Aleutian Low. The corresponding paleoceanographic and paleoclimate conditions can be divided into three stages: (1) the early Holocene (before 7000 cal. yr BP) was characterized by extensive sea-ice distribution under two low-pressure cells, which covered the western Bering Sea and the Gulf of Alaska, respectively. (2) Between 3000 and 7000 cal. yr BP, the low-pressure system over the Gulf of Alaska became weak, causing total sea-ice mass over the SBCS to retreat. (3) In the past 3000 years, prevailing southwesterly winds over the SBCS due to the developing Aleutian Low have reduced further sea-ice cover on the SBCS. These paleoclimatic changes were probably a response to ENSO variation. The timings of water mass exchanges on the SBCS coincided with sea-level change along the Alaskan Peninsula. As a result, subsequent morphologic alterations have also influenced the paleoceanographic condition of the SBCS. The effect of the surface coastal water and bottom marine water on the SBCS intensified about 6000 cal. yr BP when sea level increased.
    Type of Medium: Online Resource
    ISSN: 0959-6836 , 1477-0911
    RVK:
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2009
    detail.hit.zdb_id: 2027956-5
    SSG: 14
    SSG: 3,4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Integrative Cancer Therapies, SAGE Publications, Vol. 21 ( 2022-01), p. 153473542110730-
    Abstract: Active hexose-correlated compound (AHCC), a standardized extract of cultured Lentinula edodes mycelia, exerts antitumor effects through anti-inflammatory and immune-modulatory functions. Adjuvant therapy for patients with hepatocellular carcinoma (HCC) who have undergone curative hepatectomy has not been established. The purpose of this study was to evaluate the efficacy and safety of AHCC as adjuvant therapy in patients with advanced HCC after curative hepatectomy. Patients and methods: The study design was single-armed, non-randomized, open (no one was blinded), and uncontrolled. Patients with HCC who underwent curative hepatectomy were treated with AHCC (1 g) 3 times daily orally for 2 years. The inclusion criteria were HCC diagnosed preoperatively as stages A and B of the Barcelona clinic liver cancer (BCLC) classification and alpha-fetoprotein × protein induced by vitamin K absence or antagonist II (PIVKA-II) ≥ 10 5 for stage A. Results: A total of 29 patients were treated with AHCC, of which 25 (4 patients discontinued) were followed up. The 2-year recurrence-free survival rate after resection was 48% for those without discontinuations and 55.2% for all patients with a history of treatment. Serum albumin levels decreased to a minimum in the first postoperative month and gradually recovered to the preoperative level at 6 months. Almost no change in lymphocyte percentage was observed during follow-up. Inflammation-based prognostic scores were maintained at favorable levels after hepatectomy. Toxicity and adverse events were not observed in any patient. Conclusion: AHCC may be safe and effective in preventing HCC recurrence after curative hepatectomy, and further randomized trials of AHCC for its use in this setting are warranted. This clinical trial was registered in UMIN Clinical Trials Registry (ID UMIN000024396).
    Type of Medium: Online Resource
    ISSN: 1534-7354 , 1552-695X
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2022
    detail.hit.zdb_id: 2101248-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Cell Transplantation, SAGE Publications, Vol. 29 ( 2020-01-01), p. 096368972097045-
    Abstract: Miscarriage is the most common complication of pregnancy, and about 1% of pregnant women suffer a recurrence. Using a widely used mouse miscarriage model, we previously showed that intravenous injection of bone marrow (BM)-derived endothelial progenitor cells (EPCs) may prevent miscarriage. However, preparing enough BM-derived EPCs to treat a patient might be problematic. Here, we demonstrated the generation of mouse pluripotent stem cells (PSCs), propagation of sufficient PSC-derived cells with endothelial potential (PSC-EPs), and intravenous injection of the PSC-EPs into the mouse miscarriage model. We found that the injection prevented miscarriage. Three-dimensional reconstruction images of the decidua after tissue cleaning revealed robust fetomaternal neovascularization induced by the PSC-EP injection. Additionally, the injected PSC-EPs directly formed spiral arteries. These findings suggest that intravenous injection of PSC-EPs could become a promising remedy for recurrent miscarriage.
    Type of Medium: Online Resource
    ISSN: 0963-6897 , 1555-3892
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2020
    detail.hit.zdb_id: 2020466-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...